PARIS, France—Robotic PCI is safe and feasible for patients and improves safety and ergonomics for the operator, according to the R-Evolution study. A clinician using the R-One system (Robocath; Rouen ...
NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the clinical trial of its CorPath® PRECISE (Percutaneous ...
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today that its joint venture, Cathbot, established in 2020 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Atrium Health Sanger Heart & Vascular Institute has hit a ...
PARIS – Robocath SAS has concluded an initial clinical study in Europe to demonstrate the safety and efficacy of robotic coronary angioplasty performed using its R-One platform. Sixty-two patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback